Jäger Dorothea, Schmalenbach Caroline, Prilla Stefanie, Schrobang Jasmin, Kebig Anna, Sennwitz Matthias, Heller Eberhard, Tränkle Christian, Holzgrabe Ulrike, Höltje Hans-Dieter, Mohr Klaus
Pharmacology and Toxicology Section, Institute of Pharmacy, Rheinische Friedrich-Wilhelms-University, D-53121 Bonn, Germany.
J Biol Chem. 2007 Nov 30;282(48):34968-76. doi: 10.1074/jbc.M705563200. Epub 2007 Sep 21.
G protein-coupled receptors represent the largest superfamily of cell membrane-spanning receptors. We used allosteric small molecules as a novel approach to better understand conformational changes underlying the inactive-to-active switch in native receptors. Allosteric molecules bind outside the orthosteric area for the endogenous receptor activator. The human muscarinic M(2) acetylcholine receptor is prototypal for the study of allosteric interactions. We measured receptor-mediated G protein activation, applied a series of structurally diverse muscarinic allosteric agents, and analyzed their cooperative effects with orthosteric receptor agonists. A strong negative cooperativity of receptor binding was observed with acetylcholine and other full agonists, whereas a pronounced negative cooperativity of receptor activation was observed with the partial agonist pilocarpine. Applying a newly synthesized allosteric tool, point mutated receptors, radioligand binding, and a three-dimensional receptor model, we found that the deviating allosteric/orthosteric interactions are mediated through the core region of the allosteric site. A key epitope is M(2)Trp(422) in position 7.35 that is located at the extracellular top of transmembrane helix 7 and that contacts, in the inactive receptor, the extracellular loop E2. Trp 7.35 is critically involved in the divergent allosteric/orthosteric cooperativities with acetylcholine and pilocarpine, respectively. In the absence of allosteric agents, Trp 7.35 is essential for receptor binding of the full agonist and for receptor activation by the partial agonist. This study provides first evidence for a role of an allosteric E2/transmembrane helix 7 contact region for muscarinic receptor activation by orthosteric agonists.
G蛋白偶联受体是最大的细胞膜跨膜受体超家族。我们采用变构小分子作为一种新方法,以更好地理解天然受体从无活性到活性转换背后的构象变化。变构分子结合在内源性受体激活剂的正构区域之外。人毒蕈碱型M(2)乙酰胆碱受体是研究变构相互作用的典型受体。我们测量了受体介导的G蛋白激活,应用了一系列结构多样的毒蕈碱型变构剂,并分析了它们与正构受体激动剂的协同作用。观察到乙酰胆碱和其他完全激动剂与受体结合存在强烈的负协同性,而部分激动剂毛果芸香碱与受体激活存在明显的负协同性。应用新合成的变构工具、点突变受体、放射性配体结合和三维受体模型,我们发现不同的变构/正构相互作用是通过变构位点的核心区域介导的。一个关键表位是位于第7.35位的M(2)Trp(422),它位于跨膜螺旋7的细胞外顶部,在无活性受体中与细胞外环E2接触。Trp 7.35分别与乙酰胆碱和毛果芸香碱的变构/正构协同性差异密切相关。在没有变构剂的情况下,Trp 7.35对于完全激动剂的受体结合和部分激动剂的受体激活至关重要。本研究首次证明了变构E2/跨膜螺旋7接触区域在正构激动剂激活毒蕈碱受体中的作用。